← back to search

Rajagopal Murugan

Leiden University Medical Center · NL
Area of research
Public Health, Environmental and Occupational Health · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Malaria Research and Control, Monoclonal and Polyclonal Antibodies Research, Mosquito-borne diseases and control, and Trypanosoma species research and implications.
h-index
15
citations
1,207
works
37
NIH funding
primary concept
email

Recent publications

Tackling vaccine hyporesponsiveness through global collaboration, diverse population studies, and data integration
The Lancet Microbe 2025cited by 4position: middledoi
Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination
Immunity 2024cited by 12position: middledoi
Expression Cloning of Antibodies from Single Human B Cells
Methods in molecular biology 2024cited by 3position: middledoi
Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
npj Vaccines 2023cited by 25position: middledoi
Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein
Cell Reports 2023cited by 20position: middledoi
Molecular and functional properties of human Plasmodium falciparum CSP C‐terminus antibodies
EMBO Molecular Medicine 2023cited by 17position: middledoi
Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
npj Vaccines 2023cited by 1position: middledoi
High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire
PLoS Pathogens 2022cited by 17position: middledoi
From Multiplex Serology to Serolomics—A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome
Viruses 2021cited by 22position: middledoi
Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs
Nature Medicine 2020cited by 100position: firstdoi
From multiplex serology to serolomics – a novel approach to the antibody response against the SARS-CoV-2 proteome
medRxiv 2020cited by 2position: middledoi
A high-affinity antibody against the CSP N-terminal domain lacks <i>Plasmodium falciparum</i> inhibitory activity
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 0position: middledoi
Evolution of protective human antibodies against <i>Plasmodium falciparum</i> circumsporozoite protein repeat motifs
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 2position: firstdoi
Clonal selection drives protective memory B cell responses in controlled human malaria infection
Science Immunology 2018cited by 155position: firstdoi
Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope
Science 2018cited by 125position: middledoi
From human antibody structure and function towards the design of a novel Plasmodium falciparum circumsporozoite protein malaria vaccine
Current Opinion in Immunology 2018cited by 14position: lastdoi
Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies
Immunity 2017cited by 148position: middledoi
Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
The Journal of Experimental Medicine 2017cited by 106position: middledoi
Human cerebrospinal fluid monoclonal <i>N</i> -methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis
Brain 2016cited by 293position: middledoi
Direct high‐throughput amplification and sequencing of immunoglobulin genes from single human B cells
European Journal of Immunology 2015cited by 36position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Hedda Wardemann · German Cancer Research Center19 papers (2015–2024)Elena A. Levashina · Charité - Universitätsmedizin Berlin11 papers (2017–2023)Jean‐Philippe Julien · University of Toronto11 papers (2017–2023)Giulia Costa · Charité - Universitätsmedizin Berlin11 papers (2017–2023)S.W. Scally · Hospital for Sick Children9 papers (2017–2023)Katherine Prieto · Hospital for Sick Children8 papers (2019–2023)Alexandre Bosch · Hospital for Sick Children7 papers (2017–2022)Benjamin Mordmüller · Leiden University Medical Center5 papers (2017–2023)Anna Obraztsova · German Cancer Research Center5 papers (2023–2024)Elaine Thai · Hospital for Sick Children5 papers (2019–2023)Peter G. Kremsner · University Children's Hospital Tübingen4 papers (2017–2023)Gianna Triller · Cancer Research Center4 papers (2017–2018)Paul Kellam · Sanofi (France)4 papers (2022–2023)Stephen L. Hoffman · Sanaria4 papers (2017–2023) · 4 papers (2022–2023)Christian E. Busse · German Cancer Research Center3 papers (2015–2024)B. Kim Lee Sim · Sanaria3 papers (2017–2018) · 3 papers (2017–2023)Monique van Straaten · German Cancer Research Center3 papers (2020–2024)Katharina Imkeller · Goethe University Frankfurt3 papers (2015–2018)